Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M138Revenue $M96.8Net Margin (%)-14.4Altman Z-Score-2.5
Enterprise Value $M128EPS $-0.3Operating Margin %-13.3Piotroski F-Score2
P/E(ttm)--Beneish M-Score-3.1Pre-tax Margin (%)-14.4Higher ROA y-yN
Price/Book4.110-y EBITDA Growth Rate %-2.6Quick Ratio1.3Cash flow > EarningsY
Price/Sales1.45-y EBITDA Growth Rate %-16.7Current Ratio1.6Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-22.6Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-38.6Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M46.1ROIC % (ttm)-53.4Gross Margin Increase y-yY

Gurus Latest Trades with ENZ

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
ENZDodge & Cox 2014-12-31 Sold Out $4.1 - $5.27
($4.76)
$ 3.00-37%Sold Out0
ENZDodge & Cox 2014-09-30 Buy $4.55 - $6.08
($5.34)
$ 3.00-44%New holding15,570
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ENZ is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


ENZ: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
KASTEN BERNARD LDirector 2014-10-24Sell15,900$4.93-39.15 view
RABBANI ELAZARCEO and Secretary 2011-11-16Buy20,000$2.2931 view
WEINER BARRY WPres, CFO, Princ AO and Treasr 2011-11-16Buy20,000$2.2931 view
BALEZENTIS CARL WPres., Enzo Life Sciences 2010-12-15Sell12,724$5.12-41.41 view
Kent Stephen B HDirector 2010-10-22Sell8,000$4.3-30.23 view
Kent Stephen B HDirector 2010-08-05Sell2,500$4.47-32.89 view
Kent Stephen B HDirector 2010-06-11Sell5,000$4.29-30.07 view
Kent Stephen B HDirector 2010-03-15Sell5,000$6.15-51.22 view
KRENITSKY KEVINPresident, Enzo Clinical Labs 2009-10-15Buy6,600$7.7-61.04 view
BALEZENTIS CARL WPresident, Enzo Life Sciences 2008-10-30Sell580$5.35-43.93 view

Press Releases about ENZ :

Quarterly/Annual Reports about ENZ:

News about ENZ:

Articles On GuruFocus.com
Weekly CFO Buys Highlight: BWEN, DDMG, ZHNE, ENZ, SIRO Nov 28 2011 
Weekly CFO Buys Highlight: BWEN, ENZ, PIP, HAFC, AACC Nov 21 2011 
Enzo Biochem Inc. Reports Operating Results (10-Q) Mar 14 2011 
Enzo Biochem Inc. Reports Operating Results (10-Q) Dec 10 2010 
Enzo Biochem Inc. Reports Operating Results (10-Q) Jun 09 2010 
Enzo Biochem Inc. Reports Operating Results (10-Q) Dec 10 2009 
Weekly Top Insider Buys: Bank of America Corp., Safeway Inc., Umpqua Holdings Corp., National Penn B Oct 24 2009 
Weekly Top Insider Buys: KB Home, National Penn Bancshares Inc., Moduslink Global Solutions Inc., En Oct 20 2009 
Enzo Biochem Inc. Reports Operating Results (10-Q) Sep 04 2009 
Enzo Biochem Inc. (ENZ) Files Quarterly Report for the Period Ended on 2008-10-31 Dec 15 2008 

More From Other Websites
ENZO Biochem Reaches Patent Infringement Settlement - PRESS RELEASE Jul 22 2015
ENZO Biochem Reaches Patent Infringement Settlement Jul 22 2015
Enzo Biochem Reaches Patent Infringement Settlement Jul 22 2015
ENZO BIOCHEM INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Jul 22 2015
Enzo Biochem Reports Favorable Delaware Court Markman Hearing Ruling Jul 08 2015
Enzo Biochem Reports Favorable Delaware Court Markman Hearing Ruling Jul 08 2015
ENZO BIOCHEM INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Jul 07 2015
Enzo Biochem to Present at Cantor Fitzgerald Healthcare Conference Jul 06 2015
Enzo Biochem to Present at Cantor Fitzgerald Healthcare Conference Jul 06 2015
Enzo Biochem Reaches $7.1 Million Patent Infringement Settlement with Luminex Corporation Jul 06 2015
Enzo Biochem Reaches $7.1 Million Patent Infringement Settlement with Luminex Corporation Jul 06 2015
Edited Transcript of ENZ earnings conference call or presentation 10-Jun-15 12:30pm GMT Jun 16 2015
ENZO BIOCHEM INC Financials Jun 13 2015
10-Q for Enzo Biochem, Inc. Jun 11 2015
ENZO Biochem Reports Third Quarter Results, Including Strong Revenue Growth at Clinical Labs... Jun 09 2015
Enzo Biochem reports 3Q loss Jun 09 2015
Enzo Biochem reports 3Q loss Jun 09 2015
ENZO BIOCHEM INC Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD... Jun 09 2015
Enzo Biochem Reports Third Quarter Results, Including Strong Revenue Growth at Clinical Labs... Jun 09 2015
Q3 2015 Enzo Biochem Inc Earnings Release - After Market Close Jun 09 2015

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK